Cystic fibrosis: diagnosis and management (NG78)Product type:GuidanceProgramme:NICE guidelinePublished: 25 October 2017
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation (TA398)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 July 2016
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis (TA276)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 March 2013
Mannitol dry powder for inhalation for treating cystic fibrosis (TA266)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 November 2012